LEADER 01732cam a22003495i 4500001    99131234389806421
005    20210430182010.0
006    m        d
007    cr cn|||||||||
008    020129s2021    dcu     o    i00  0 eng^^
024 7  10.1596/35281 |2doi
035    (CKB)4920000001209418
035    (The World Bank)35281
035    (US-djbf)35281
035    (EXLCZ)994920000001209418
040    DJBF |beng |cDJBF |erda
110 2  World Bank Group.
245 10 Assessing Country Readiness for COVID-19 Vaccines : |bFirst Insights from the Assessment Rollout.
246    Assessing Country Readiness for COVID-19 Vaccines
264  1 Washington, D.C. : |bThe World Bank, |c2021.
336    text |btxt |2rdacontent
337    computer |bc |2rdamedia
338    online resource |bcr |2rdacarrier
347    data file |2rda
490 1  Other Health Study.
520 3  The global COVID-19 vaccination campaign, the largest public health initiative ever undertaken, presents challenges unprecedented in scale, speed and specificities, especially in low and middle-income countries. In November 2020, anticipating the availability of safe and effective vaccines for COVID-19, the World Bank together with WHO, UNICEF, the Global Fund, and Gavi rolled out readiness assessments in more than 100 low and middle-income countries. The key insights from the assessments to date present a high-level snapshot of country readiness to deploy COVID-19 vaccines based on initial findings from ongoing assessments in 128 countries.
650  4 Coronavirus
650  4 COVID-19
650  4 Disease Control and Prevention
650  4 Health, Nutrition and Population
650  4 Immunizations
650  4 Readiness Assessment
830  0 Other Health Study.
830  0 World Bank e-Library.
906    BOOK